Alithea Genomics

Alithea Genomics is a Swiss biotechnology company that provides extraction-free, high-throughput RNA sequencing solutions for drug discovery and chemical safety assessments based in Switzerland.

Here are key aspects of the company:

• Products & Services: The company offers extraction-free bulk and single-cell RNA-seq workflows that allow researchers to profile thousands of compounds or conditions directly from frozen cell pellets without tedious RNA isolation.
• Industries: Their technologies support pre-clinical drug discovery, hit identification, mechanism mapping, toxicity signal prediction, and chemical safety evaluations for sustainable products.
• Innovation: Alithea Genomics utilizes highly optimized barcoded primer sets to enable up to 384 library preparations in a single tube while capturing rare or low-input cells with full-length sequencing sensitivity that droplet methods cannot provide.

Alithea Genomics empowers laboratories worldwide to democratize transcriptomic screening by delivering robust, automation-friendly molecular insights that accelerate decision-making from early hit triage to toxicology and dose optimization.